Sunitinib Malate 25 mg/1 (Sunitinib Malate CAPSULE) 25 mg/1

Sunitinib Malate 25 mg capsules are a medication used for targeted therapy. This oral medication is designed to inhibit certain proteins that may contribute to cancer cell growth. Learn more about its uses and effects.

Strength

25 mg/1

Pack Size

28 CAPSULE in 1 BOTTLE, PLASTIC (0378-6679-28)

Manufacturer / TM Owner

Mylan Pharmaceuticals Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Sunitinib Malate 25 mg capsules are primarily used in the treatment of certain types of cancer. This medication works by targeting specific proteins that play a role in the growth and spread of cancer cells. It is often prescribed for conditions like renal cell carcinoma and gastrointestinal stromal tumors. Patients should consult their healthcare provider to understand what Sunitinib Malate is used for in their specific case.

Side Effects

Common effects of Sunitinib Malate 25 mg capsules may include fatigue, nausea, and diarrhea. Some users might experience changes in skin color or hand-foot syndrome, which can cause redness and swelling on the palms and soles. These effects can vary from person to person, and it is important to discuss any concerns with a healthcare professional.

Precautions & Warnings

Sunitinib Malate 25 mg capsules should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare provider. Patients should inform their doctor about any pre-existing conditions or other medications they are taking to avoid potential complications.

Avoid Interactions

Sunitinib Malate 25 mg capsules may interact with certain medications, including those that are metabolized by the liver. Alcohol consumption should be avoided as it may exacerbate side effects. Patients should also be cautious when taking other medications that affect blood pressure or heart function.

Frequently Asked Questions

Sunitinib Malate is primarily used in the treatment of certain types of cancer, including renal cell carcinoma and gastrointestinal stromal tumors.

Sunitinib Malate 25 mg capsules are taken orally, usually once daily. Follow the specific instructions provided by your healthcare provider.

Common side effects may include fatigue, nausea, diarrhea, and changes in skin color. Some users may also experience hand-foot syndrome.

It is generally advised to avoid alcohol while taking Sunitinib Malate, as it may worsen side effects.

If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular schedule.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.